2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      What is the significance, if any, of the increased incidence of stent thrombosis with dual therapy of dabigatran 110 mg twice daily and clopidogrel in the RE-DUAL PCI trial?

      European Journal of Internal Medicine
      Elsevier BV

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          European Journal of Internal Medicine
          European Journal of Internal Medicine
          Elsevier BV
          09536205
          April 2018
          April 2018
          : 50
          : e27-e28
          Article
          10.1016/j.ejim.2017.12.009
          41405ab5-de2e-4833-929d-9fe4f3b60361
          © 2018

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article